Stock Analiz

Amgen Inc. (AMGN) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Amgen’s revenue went from $23.0B in fiscal 2016 to $36.8B in fiscal 2025, growth of about 5.4% a year.

Net income in fiscal 2025 was $7.7B, a net margin of 21.0%; the best year in this period was 2018 with $8.4B.

Over the twelve months to September 30, 2026, revenue was $38.9B and net income $9.4B.

Free cash flow was $8.1B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 28% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $23.0B162017: $22.8B172018: $23.7B182019: $23.4B192020: $25.4B202021: $26.0B212022: $26.3B222023: $28.2B232024: $33.4B242025: $36.8B25$36.8B
Net income
2016: $7.7B162017: $2.0B172018: $8.4B182019: $7.8B192020: $7.3B202021: $5.9B212022: $6.6B222023: $6.7B232024: $4.1B242025: $7.7B25$7.7B
Free cash flow
2016: $9.6B162017: $10.5B172018: $10.6B182019: $8.5B192020: $9.9B202021: $8.4B212022: $8.8B222023: $7.4B232024: $10.4B242025: $8.1B25$8.1B
EPS (diluted)
2016: $10.24162017: $2.69172018: $12.62182019: $12.88192020: $12.31202021: $10.28212022: $12.11222023: $12.49232024: $7.56242025: $14.2325$14.23

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$38.9B$36.8B$33.4B$28.2B$26.3B$26.0B$25.4B$23.4B$23.7B$22.8B$23.0B
Gross profit$27.6B$24.7B$20.6B$19.7B$19.9B$19.5B$19.3B$19.0B$19.6B$18.8B$18.8B
Operating income$12.6B$9.1B$7.3B$7.9B$9.6B$7.6B$9.1B$9.7B$10.3B$10.0B$9.8B
Net income$9.4B$7.7B$4.1B$6.7B$6.6B$5.9B$7.3B$7.8B$8.4B$2.0B$7.7B
EPS (diluted)$17.25$14.23$7.56$12.49$12.11$10.28$12.31$12.88$12.62$2.69$10.24
R&D$7.8B$7.3B$6.0B$4.8B$4.4B$4.8B$4.2B$4.1B$3.7B$3.6B$3.8B
Revenue growth—+10.0%+18.6%+7.1%+1.3%+2.2%+8.8%−1.6%+3.9%−0.6%+6.1%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$12.0B$10.0B$11.5B$8.5B$9.7B$9.3B$10.5B$9.2B$11.3B$11.2B$10.4B
Capital spending-$2.5B-$1.9B-$1.1B-$1.1B-$936M-$880M-$608M-$618M-$738M-$664M-$738M
Free cash flow$9.6B$8.1B$10.4B$7.4B$8.8B$8.4B$9.9B$8.5B$10.6B$10.5B$9.6B
Dividends paid$5.4B$5.1B$4.8B$4.6B$4.2B$4.0B$3.8B$3.5B$3.5B$3.4B$3.0B
Buybacks—$0$200M$0$6.4B$5.0B$3.5B$7.7B$17.8B$3.2B$3.0B
Stock-based pay$493M$494M$530M$431M$401M$341M$330M$308M$311M$329M$311M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$9.1B$12.0B$10.9B$9.3B$8.0B$10.6B$8.9B$29.3B$41.7B$3.2B
Debt—$55.4B$60.9B$65.4B$39.6B$34.0B$33.4B$30.4B$33.9B$35.3B$34.6B
Equity—$8.7B$5.9B$6.2B$3.7B$6.7B$9.4B$9.7B$12.5B$25.2B$29.9B
Total assets—$90.6B$91.8B$97.2B$65.1B$61.2B$62.9B$59.7B$66.4B$80.0B$77.6B
Shares (diluted)546M542M541M538M541M573M590M609M665M735M754M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin70.9%67.2%61.5%70.0%75.7%75.2%75.8%81.3%82.7%82.2%81.9%
Operating margin32.4%24.7%21.7%28.0%36.3%29.4%35.9%41.4%43.2%43.6%42.6%
Net margin24.1%21.0%12.2%23.8%24.9%22.7%28.6%33.6%35.4%8.7%33.6%
FCF margin24.6%22.0%31.1%26.1%33.4%32.3%38.9%36.5%44.5%46.0%41.8%
ROIC—12.2%9.7%9.4%19.7%16.5%19.1%20.7%19.4%13.0%12.8%
ROE—89.1%69.6%107.8%179.0%88.0%77.2%81.1%67.2%7.8%25.9%

Frequently asked questions

What is Amgen’s annual revenue?

$36.8B in fiscal 2025 and $38.9B over the twelve months to September 30, 2026.

How much profit does Amgen make?

Net income was $7.7B in fiscal 2025 (net margin 21.0%).

Is Amgen’s revenue growing?

Yes: revenue rose 10.0% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.